DHG Pharmaceutical JSC (STC:DHG) Debt-to-Asset : 0.01 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STC:DHG DHG Pharmaceutical JSC STC:DHG
79 GF Score
Price ₫95,500.00
GF Value ₫113,107.67
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DHG Pharmaceutical JSC Debt-to-Asset?

DHG Pharmaceutical JSC STC:DHG -0.31% 79 Debt-to-Asset is 0.01 as of Jun. 2026. GuruFocus rates STC:DHG with a GF Score™ of 79/100 and a GF Value™ of ₫113,107.67 (Modestly Undervalued). The stock has 4 warning signs investors should review.

DHG Pharmaceutical JSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₫32,561 Mil. DHG Pharmaceutical JSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₫0 Mil. DHG Pharmaceutical JSC's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2026 was ₫5,005,488 Mil. DHG Pharmaceutical JSC's debt to asset for the quarter that ended in Jun. 2026 was 0.01.

DHG Pharmaceutical JSC  (STC:DHG) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

DHG Pharmaceutical JSC Debt-to-Asset Related Terms

DHG Pharmaceutical JSC Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for DHG Pharmaceutical JSC's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DHG Pharmaceutical JSC Debt-to-Asset Chart

DHG Pharmaceutical JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.02 0.10 0.12 0.01

DHG Pharmaceutical JSC Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.16 0.01 0.01 0.01

STC:DHG vs ZTS: Debt-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DHG Pharmaceutical JSC Debt-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where DHG Pharmaceutical JSC's Debt-to-Asset falls into.


STC:DHG
79GF Score
DHG Pharmaceutical JSC STC:DHG
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DHG Pharmaceutical JSC Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

DHG Pharmaceutical JSC's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(32560.699 + 0) / 5173881.629
=0.01

DHG Pharmaceutical JSC's Debt-to-Asset for the quarter that ended in Jun. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(32560.699 + 0) / 5005487.53
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.01 mean?
DHG Pharmaceutical JSC (STC:DHG) has a Debt-to-Asset of 0.01 as of Jun. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on DHG Pharmaceutical JSC and its competitors.
Is DHG Pharmaceutical JSC's Debt-to-Asset too high?
DHG Pharmaceutical JSC's current Debt-to-Asset is 0.01. Overall, DHG Pharmaceutical JSC has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's Debt-to-Asset compare to ZTS?
DHG Pharmaceutical JSC's Debt-to-Asset of 0.01 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Drug Manufacturers company?
A good Debt-to-Asset depends on the Drug Manufacturers industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on DHG Pharmaceutical JSC and its competitors. DHG Pharmaceutical JSC's current Debt-to-Asset is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,107.67, compared to a current price of ₫95,500.00 — trading 15.6% below its estimated fair value. The current Debt-to-Asset is 0.01. DHG Pharmaceutical JSC's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current Debt-to-Asset is 0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?

Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued. The current stock price of ₫95,500.00 is trading 15.6% below its estimated GF Value™ of ₫113,107.67. GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.

Key valuation signals for STC:DHG:

  • Debt-to-Asset: 0.01
  • GF Value™: ₫113,107.67 vs. price of ₫95,500.00 (15.6% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DHG Pharmaceutical JSC Business Description

Address 288 Bis Nguyen Van Cu, An Hoa Ward, Ninh Kieu District, Can Tho, VNM
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
79GF Score

Get the complete analysis for STC:DHG

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫95,500.00
Price
₫113,107.67
GF Value